Company news
Medipal Holdings Corporation news in 2025
Medipal Holdings Corporation's news releases, calls and decks from 2025, newest first.
Notice Regarding Results and Completion of Acquisition of Treasury Stock and Number of Cancellation Shares of Treasury Stock
November 5, 2025
Notice Regarding Business Transfer of Consolidated Subsidiary
October 28, 2025
Notice Regarding MP AGRO CO., LTD.'s Acquisition of All Shares of Cygni Holdings, Inc.
October 9, 2025
Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by Ministry of Health, Labour and Welfare of Japan
September 29, 2025
MEDIPAL HOLDINGS and JCR Pharmaceuticals Sign Global Licensing and Japan Co-Development Agreement for JR-479, a Novel Therapy for GM2 Gangliosidosis
September 2, 2025
Notice Regarding Progress of Acquisition of Treasury Stock
August 4, 2025
Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by European Commission (EC)
June 24, 2025
Notice of Acquisition of Shares of PHARUMO, Inc.
June 10, 2025
Notice of Completion of MEDICEO “Medical Distribution Center Kobe”
May 27, 2025
Notice of Transfer of Representative Director (Additional Selection) and Acting President
May 23, 2025
Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by the U.S. FDA
May 7, 2025
Decks in 2025
- Q2 FY2025 Earnings Presentation
Earnings · 29 slides · Nov 5, 2025
- Q2 FY2025 Earnings Presentation
Earnings · 29 slides · Nov 5, 2025
- Q1 FY2025 Earnings Presentation
Earnings · 14 slides · Aug 5, 2025
- Q1 FY2025 Earnings Presentation
Earnings · 14 slides · Aug 5, 2025
- FY2024 Earnings Presentation
Earnings · 34 slides · May 13, 2025
- FY2024 Earnings Presentation
Earnings · 34 slides · May 13, 2025
- Q3 FY2024 Earnings Presentation
Earnings · 22 slides · Feb 10, 2025
- Q3 FY2024 Earnings Presentation
Earnings · 22 slides · Feb 10, 2025